Revisioning Brain Cancer Care Delivery through Digital Transformation

At Mayo Clinic, the Neuro-Oncology Anywhere clinical trial portfolio is transforming how brain cancer care is delivered. Using telehealth visits, remote patient education services, device-based patient monitoring technologies, digital chemotherapy toxicity checks, home or local phlebotomy services, mail-order drug delivery, and virtual tumor boards, the Neuro-Oncology Anywhere clinical trials are bringing brain cancer care to patients' homes. The platform started with remote cognitive assessments for patients who have received intracranial radiation therapy. With its latest iteration, the Neuro-Oncology Anywhere portfolio now includes home chemotherapy services that allows for administration of both conventional and experimental therapeutics without need for patient travel. The digital platform created by these clinical trials is accelerating drug development and testing while simultaneously making access to care easier for individuals with brain cancer.